The Innovation for Health Learning Laboratory provides the facilities to ensure our students are exposed to research-led teaching connected to our three research grand challenges: science delivering global wellbeing; sustainable cities, communities and economies; and connecting societies and cultures.
Below, discover a selection of projects that fall under the Innovation for Health umbrella.
Blue light and human attentiveness
This project aims to use the 5G testbed, combining robotics, wearable technologies and remote monitoring to enable carers to observe the behaviour of persons they are caring for with dementia without needing to be at their specific locations.
The project involves Surrey and Borders NHS Trust together with Royal Holloway, Kent and Surrey and Sussex Academic Health Science Network together with the Alzheimer Society, local clinical commissioning groups and a number of charities. The findings aim to support reactive and informed decision-making for care givers, clinical teams and support groups, ultimately transforming the delivery of dementia care in the UK.
"This project has significant potential to improve the outcomes of people with dementia and their families through the use of innovative technologies."Roma Maguire
"The Internet of Things testbed will provide continuous monitoring observation data in a secure environment"Dr Payam Barnaghi
The Electronic Symptom Management using Advanced symptom management system Remote Technology (eSMART) project involves giving patients a mobile phone with an app-like programme to help them identify and record their chemotherapy symptoms twice a day. This information is sent securely to a system that assesses these symptoms and triggers an immediate alert to doctors or nurses if the patient requires assistance. The mobile communication also offers real-time information and advice to patients on how to manage their symptoms at home without the need to travel to hospital. The project is supported by a EURO six million grant from the EU, funding a trial involving 1,000 patients in England, Austria, Greece, Holland, Ireland and Norway with the hope that this type of patient monitoring will be integrated into routine cancer care in the future.
The aim of i-Sense is to detect outbreaks of infectious diseases earlier than ever before to protect patients and populations. This five-year £11 million EPSRC funded interdisciplinary research collaboration brings together a team of biochemists, chemists, physicists, engineers and computer scientists, microbiologists, statisticians, applied mathematicians, architects, philosophers, clinicians and epidemiologists, led by Professor Rachel McKendry at UCL.
It involves a range of academic, government and industrial partners including Imperial College London, London School of Hygiene and Tropical Medicine, Newcastle University, University of Surrey, Public Health England, Google, Microsoft and the Wellcome Trust Africa Centre, amongst others. The delivery of the i-Sense vision is through engineering a new generation of low-cost early warning sensing systems that utilise web information such as search engine queries and social media posts, in combination with mobile phone connected diagnostics, to widen access to testing in home settings.
The core research programme brings together collective expertise in disruptive sensing technologies spanning end user needs to biomarker discovery, biomimetic capture ligands, advanced nanomaterials, low power sensors with wireless connectivity, big data analytics, apps and dashboards, and the creation of testbeds to evaluate technologies in the UK and developing countries.